MNKD

MANNKIND CORP

Latest Form 4:Sale$159KbyBinder Steven B. (Director) · filed Aug 11, 2026

MANNKIND CORP (MNKD) has 32 SEC Form 4 filings (63 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Aug 11, 2026.

The most active filer is Chief Executive Officer Castagna Michael with 5 filings. Insiders have net sold $276K over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Michael E. Castagna
  • Employees:403
  • HQ:Danbury, CA, US
  • IPO:2004-07-28

Insider Buying

$259K

reported purchases (SEC code P)

Insider Selling

$3.3M

reported sales (SEC code S)

Unique Insiders

5

in the rolling window

Market Cap

$1.3B

latest known value

Source
Sale$159KAug 11SEC ↗
Sale$98KJul 18SEC ↗
Sale$213KJul 18SEC ↗
Binder Steven B.First filing
Sale$56KMay 14SEC ↗
Thomson DavidFirst in 5 months
Sale$10KMay 14SEC ↗
Purchase$259KMar 10SEC ↗
Tross Stuart AFirst in 4 months
Sale$298KJan 9SEC ↗
Sale$395KDec 19SEC ↗
Sale$125KDec 16SEC ↗
Sale$128KDec 16SEC ↗
Thomson DavidFirst filing
Sale$823KDec 4SEC ↗
Castagna MichaelFirst filing
Sale$601KDec 4SEC ↗
Singh Sanjay RFirst filing
Sale$94KNov 14SEC ↗
Tross Stuart AFirst filing
Sale$251KSep 17SEC ↗

Related companies

MANNKIND CORP is in the Healthcare sector.